Swine Influenza

Swine influenza is an acute, highly contagious respiratory disease of pigs caused by type A influenza viruses. This viral infection has been recognized in swine populations since the 1918 influenza pandemic and remains one of the most common respiratory diseases affecting commercial pig operations worldwide. The disease is characterized by rapid onset of clinical signs affecting a high percentage of pigs within an exposed group, followed by relatively quick recovery in uncomplicated cases. Understanding swine influenza is essential not only for pig health management but also for public health considerations given the zoonotic potential of these viruses.

Swine influenza A viruses circulate continuously in pig populations globally, with endemic strains varying by geographic region. The primary subtypes affecting pigs include H1N1, H3N2, and H1N2, though other combinations occur through reassortment events. Unlike many other swine respiratory pathogens, influenza viruses demonstrate remarkable genetic plasticity, constantly evolving through antigenic drift and occasionally undergoing dramatic changes through reassortment between different viral strains. This genetic variability has important implications for vaccine effectiveness and creates ongoing challenges for disease control programs.

The economic impact of swine influenza on pig production results primarily from reduced growth performance rather than mortality, which typically remains low in uncomplicated outbreaks. Affected pigs experience fever, anorexia, and lethargy that suppress weight gain for several days to two weeks. When secondary bacterial pneumonia complicates viral infection, losses increase substantially. The contribution of influenza to the porcine respiratory disease complex adds to its economic significance, as it predisposes pigs to infection with bacterial pathogens that cause more severe clinical disease.

The zoonotic nature of swine influenza demands attention from both agricultural and public health perspectives. Pigs can serve as mixing vessels for influenza viruses from different species, potentially generating novel reassortant viruses with pandemic potential. The 2009 H1N1 pandemic originated from a virus containing genetic elements from swine, avian, and human influenza strains. Bidirectional transmission between pigs and humans occurs regularly, necessitating appropriate biosecurity measures and awareness among farm workers and veterinary personnel working with swine populations.

Swine influenza A viruses belong to the family Orthomyxoviridae and are classified by their surface glycoproteins hemagglutinin and neuraminidase, which determine subtype designation. The hemagglutinin protein mediates viral attachment to host cells and is the primary target of neutralizing antibodies, while neuraminidase facilitates viral release from infected cells. Current endemic swine influenza subtypes include classical H1N1, human-like H3N2, reassortant H1N2, and the 2009 pandemic H1N1 lineage that became established in pig populations following reverse zoonotic transmission from humans. Continuous viral evolution through antigenic drift creates strain diversity that complicates immune protection.

Viral transmission occurs primarily through respiratory secretions via direct pig-to-pig contact or aerosol spread over short distances. Infected pigs shed large quantities of virus in nasal secretions beginning approximately one day after infection and continuing for seven to ten days. Aerosol transmission can occur over distances of several meters within buildings and potentially between adjacent facilities under certain conditions. The virus survives for limited periods in the environment, with persistence favored by cool temperatures and moderate humidity. Fomite transmission through contaminated equipment, clothing, and vehicles can occur but is considered less important than respiratory routes.

Human introduction of influenza virus to pig populations represents an important epidemiological pathway, as pigs are susceptible to human seasonal influenza strains. Farm workers, veterinarians, and other personnel experiencing influenza illness can transmit virus to susceptible pigs through close contact. This reverse zoonotic transmission has been documented repeatedly and has introduced human-adapted influenza strains into swine populations where they continue to circulate and evolve. The ability of pigs to support replication of both swine and human influenza viruses creates opportunities for genetic reassortment when dual infections occur.

Risk factors for swine influenza outbreaks include introduction of naive pigs into infected populations, seasonal variations with increased incidence during cooler months, and management practices that increase animal density or stress. Commingling pigs from multiple sources at markets, fairs, or in grow-finish facilities brings together animals with different immune backgrounds and viral exposure histories. Temperature fluctuations and ventilation challenges during fall and winter months coincide with peak influenza activity. Concurrent infections with other respiratory pathogens, particularly PRRSV and Mycoplasma hyopneumoniae, increase susceptibility to influenza and worsen clinical outcomes.

The pathogenesis of swine influenza involves viral attachment to and replication within respiratory epithelial cells throughout the respiratory tract. The hemagglutinin protein binds to sialic acid residues on the cell surface, with the specific linkage configuration determining host species tropism. Following cell entry, viral replication produces large numbers of progeny virions that spread to adjacent cells, progressively infecting the respiratory epithelium. The resulting cell damage and inflammatory response produce the clinical signs of acute respiratory disease. In uncomplicated infections, epithelial repair begins within days and progresses to complete resolution over one to two weeks.

Early warning signs of swine influenza often appear suddenly, with explosive onset affecting a large proportion of pigs within an exposed group over a very short timeframe. The initial observations may include a few pigs appearing quiet and reluctant to rise for feeding, with rapid progression to widespread lethargy throughout the affected group within 24 to 48 hours. Fever precedes other clinical signs and may be detected during routine temperature monitoring before obvious illness develops. Reduced feed consumption, often the first measurable production impact, occurs simultaneously with fever onset.

Respiratory signs dominate the clinical presentation of swine influenza and provide important diagnostic clues. Coughing appears early in the disease course and becomes pronounced within two to three days of onset, often described as a harsh, nonproductive cough that sweeps through affected groups in waves. Sneezing and nasal discharge accompany coughing, with discharge initially serous and potentially becoming mucopurulent if secondary bacterial infection develops. Labored breathing with increased respiratory rate reflects the extent of respiratory tract involvement, though severe dyspnea is uncommon in uncomplicated influenza.

Behavioral changes during influenza infection reflect the systemic effects of fever and viral illness. Affected pigs display marked lethargy, with reluctance to rise even when feed is offered, and reduced interaction with penmates. Huddling behavior may increase as febrile pigs experience chilling, particularly in inadequately heated facilities. Competitive feeding activity diminishes as sick pigs lack appetite and energy to maintain normal social interactions. Activity levels throughout affected groups decline noticeably compared to pre-outbreak patterns.

Physical examination findings in influenza-affected pigs include elevated rectal temperature, typically ranging from 104 to 108°F (40 to 42.2°C) during the acute phase. Conjunctivitis with ocular discharge and swollen eyelids gives affected pigs a characteristic appearance. Nasal mucosa appears congested and may show petechial hemorrhages. Auscultation of the respiratory tract reveals increased respiratory sounds, wheezes, and crackles in more severely affected individuals. Lymph nodes, particularly those draining the respiratory tract, may be palpably enlarged.

Symptom progression in uncomplicated swine influenza follows a predictable course toward recovery within approximately one week. Fever typically resolves within three to five days, followed by gradual improvement in appetite and activity. Coughing may persist for several days after other signs abate as respiratory epithelium regenerates. Growth rates recover over one to two weeks following clinical resolution. However, secondary bacterial pneumonia can complicate recovery, producing persistent or worsening respiratory signs, prolonged fever, and occasionally mortality.

Emergency symptoms requiring immediate veterinary intervention include respiratory distress severe enough to cause open-mouth breathing or cyanosis, mortality rates exceeding those expected for uncomplicated influenza, neurological signs suggesting secondary complications, and failure of expected clinical improvement within the normal timeframe. While uncomplicated swine influenza typically produces low mortality, severe outbreaks or those complicated by co-infections can produce significant losses requiring aggressive intervention. Sudden increases in mortality during apparent influenza outbreaks warrant investigation for concurrent diseases or secondary bacterial infections.

Clinical diagnosis of swine influenza relies on recognition of characteristic presentation patterns including explosive onset affecting a high proportion of pigs, predominant respiratory signs with coughing and fever, and rapid recovery in uncomplicated cases. The combination of high morbidity with low mortality, along with the distinctive harsh cough spreading through groups in waves, strongly suggests influenza involvement. Seasonality of outbreaks, with increased incidence during cooler months, supports clinical suspicion. However, laboratory confirmation is essential for definitive diagnosis given the similarity of clinical presentations among various respiratory pathogens.

Laboratory diagnosis typically employs polymerase chain reaction testing for detection of influenza A viral nucleic acid in nasal swabs or lung tissue samples. PCR offers rapid turnaround time, high sensitivity, and the ability to detect multiple influenza subtypes simultaneously. Sample collection during the acute febrile phase of illness yields the highest detection rates, as viral shedding declines rapidly after the first week of infection. Nasal swabs from recently affected pigs or fresh lung tissue from pigs euthanized or dying during the acute phase provide optimal specimens. Real-time PCR assays can provide subtype identification based on hemagglutinin and neuraminidase gene sequences.

Viral isolation in embryonated chicken eggs or cell culture remains the gold standard for definitive diagnosis and allows comprehensive characterization of isolates. Isolated viruses can be subtyped, sequenced, and compared to vaccine strains to assess potential vaccine effectiveness. However, the time required for isolation and characterization limits its utility for immediate clinical decisions. Serological testing detects antibodies to influenza virus and can demonstrate seroconversion when paired samples are tested, though antibody detection alone may reflect historical exposure rather than current infection.

Differential diagnosis includes other causes of acute respiratory disease in swine, particularly those producing similar clinical presentations. PRRS virus infection can produce respiratory disease in growing pigs, though typically with different epidemiological patterns and potentially more severe immunosuppression. Mycoplasma hyopneumoniae causes chronic coughing but without the explosive onset characteristic of influenza. Actinobacillus pleuropneumoniae produces acute respiratory disease with potentially high mortality that may resemble severe influenza outbreaks. The porcine respiratory disease complex frequently involves multiple pathogens, making comprehensive diagnostic panels valuable for identifying all contributing factors.

Direct antiviral treatment of swine influenza is generally not practiced in commercial pig production, as antiviral drugs approved for human influenza are not labeled for use in pigs and would raise food safety concerns. Treatment strategies therefore focus on supportive care to maintain pig comfort during the acute illness and antimicrobial therapy to prevent or treat secondary bacterial complications. The self-limiting nature of uncomplicated influenza in healthy pigs means that supportive measures aimed at maintaining feed and water intake often suffice for most affected animals.

Antimicrobial therapy addresses secondary bacterial pneumonia, which represents the primary cause of mortality in influenza-affected swine populations. Selection of appropriate antibiotics should target common respiratory pathogens including Pasteurella multocida, Actinobacillus pleuropneumoniae, Streptococcus suis, and Haemophilus parasuis. Injectable antibiotics such as ceftiofur, florfenicol, or tulathromycin provide rapid treatment for individual pigs showing signs of bacterial complication. Water medication offers a practical route for population-level treatment during outbreaks, though consumption may be reduced in acutely ill groups.

Anti-inflammatory medications help control fever and improve pig comfort during acute illness, potentially maintaining appetite and reducing growth impacts. Nonsteroidal anti-inflammatory drugs including meloxicam, flunixin meglumine, and ketoprofen effectively reduce fever and inflammation when administered to affected pigs. The decision to treat individual pigs versus entire groups depends on outbreak severity, facility capabilities, and economic analysis. In mild outbreaks, individual treatment of the most severely affected pigs may suffice, while widespread clinical disease may warrant population-level intervention.

Supportive care measures address the consequences of fever and anorexia during acute illness. Ensuring ready access to fresh, clean water encourages hydration in febrile pigs. Low-mounted supplemental waterers or water cups may benefit pigs reluctant to use standard nipple drinkers. Fresh feed offered in small amounts may stimulate appetite in recovering pigs. Temperature management becomes particularly important during influenza outbreaks, as febrile pigs may become chilled when fever breaks, and inadequate environmental temperature prolongs recovery.

Herd management during outbreaks aims to prevent spread to unaffected groups while supporting recovery in affected populations. Movement restrictions prevent exposure of naive groups until the outbreak resolves. All-in-all-out production flow allows affected groups to recover together without ongoing viral transmission from newly introduced susceptible pigs. Enhanced monitoring identifies individual pigs requiring treatment and tracks population-level recovery progression. Record-keeping documents outbreak timing, clinical signs, treatments administered, and outcomes for future reference.

Withdrawal time compliance for all administered medications must be carefully observed to ensure food safety for pigs destined for slaughter. Treatment records should document all drugs used, including dosages, administration routes, and dates, allowing accurate calculation of withdrawal periods. When mortality or treatment rates suggest potential food safety concerns, consultation with regulatory authorities may be appropriate. Economic analysis balancing treatment costs against expected performance benefits guides decision-making about treatment intensity and duration during outbreaks.

Recovery from uncomplicated swine influenza proceeds rapidly, with most pigs returning to normal feed intake and activity within five to seven days of symptom onset. Fever resolution typically occurs within three to five days, followed by gradual improvement in appetite and restoration of normal behavior patterns. Coughing may persist for several days after other signs resolve as damaged respiratory epithelium regenerates. The characteristic pattern of rapid recovery affecting the majority of exposed pigs helps distinguish influenza from other respiratory conditions that produce more prolonged illness.

Post-acute monitoring ensures that recovery proceeds as expected and identifies pigs developing complications requiring additional intervention. Daily observation should note the proportion of pigs showing continued clinical signs, assess group appetite through feed disappearance monitoring, and identify individuals with persistent or worsening symptoms. Temperature monitoring of a sample of previously affected pigs confirms fever resolution. Pigs showing prolonged fever, worsening respiratory signs, or failure to resume eating should be evaluated for secondary bacterial pneumonia or other complications.

Growth performance recovery requires one to two weeks following clinical resolution before affected pigs return to normal weight gain trajectories. The magnitude of growth depression depends on outbreak severity, duration of clinical signs, and the occurrence of secondary complications. Studies have documented average daily gain reductions of 10 to 20 percent during the acute illness period, with gradual recovery to baseline performance over subsequent weeks. Feed efficiency similarly declines during illness and recovery periods, adding to production costs.

Return to production considerations acknowledge the temporary setbacks in growth performance while recognizing that most pigs fully recover without lasting consequences. Affected groups may require additional finishing time to reach target market weights, with economic calculations determining whether extended feeding periods are profitable. Breeding stock experiencing influenza generally return to normal reproductive function following recovery, though stress of illness during pregnancy warrants monitoring of subsequent farrowing outcomes. Recovered pigs develop immunity to the infecting strain but remain susceptible to antigenically distinct variants.

Vaccination represents the primary prevention tool for swine influenza and is widely practiced in commercial pig production. Inactivated whole-virus vaccines containing antigens matched to circulating strains provide the foundation of most immunization programs. Commercial multivalent vaccines include antigens from multiple influenza subtypes to broaden protection. Autogenous vaccines produced from strains isolated from the specific herd offer targeted protection when commercial products fail to cover circulating variants. Vaccination programs typically target breeding animals to provide maternal antibody protection to piglets and reduce viral shedding from sows, with growing pig vaccination implemented where clinical disease remains problematic.

Biosecurity measures prevent introduction of new influenza strains and reduce viral spread within operations. Personnel policies should discourage farm entry by individuals experiencing influenza-like illness, with sick leave policies supporting compliance. Hand hygiene and personal protective equipment reduce transmission risk from infected workers to pigs and vice versa. Boot and clothing changes at farm entry limit introduction of contaminated fomites. Visitors and non-essential personnel should be restricted from pig areas, particularly during influenza season.

Swine exhibition and show pig biosecurity deserves special attention given the documented role of fairs and exhibitions in influenza transmission. Pigs returning from exhibitions should be isolated before rejoining home herds, with monitoring for development of respiratory disease. Exhibitors should practice hand hygiene and avoid contact between their pigs and unfamiliar animals. The 2009 H1N1 pandemic emergence and subsequent variant virus detections have heightened awareness of exhibition swine as a reservoir for zoonotic influenza transmission.

Environmental management supports respiratory health and reduces influenza transmission within facilities. Adequate ventilation removes airborne pathogens and maintains air quality that supports respiratory defenses. Temperature control prevents the stress of chilling that increases disease susceptibility. Stocking density management reduces direct contact transmission opportunities and maintains air quality. All-in-all-out pig flow prevents ongoing viral circulation between age groups that perpetuates endemic infection.

Surveillance programs track influenza activity within herds and identify circulating strains for vaccine selection. Periodic diagnostic testing during respiratory disease outbreaks determines whether influenza is involved and characterizes the strains present. Participation in national or regional surveillance programs contributes to understanding of influenza epidemiology and provides advance warning of emerging variants. Sequencing of diagnostic isolates allows comparison to vaccine strains and informs decisions about vaccine program modifications.

Daily management in herds affected by or at risk for swine influenza emphasizes consistent observation, environmental monitoring, and rapid response to emerging problems. Caretakers should walk pens systematically during each shift, observing pigs for coughing, lethargy, and other respiratory signs. Feed disappearance monitoring provides early warning of appetite decline that may precede obvious clinical signs. Temperature monitoring during routine handling identifies febrile pigs requiring attention. Training personnel to recognize influenza presentation patterns ensures rapid detection when outbreaks occur.

Housing and environmental management directly influence influenza transmission and clinical expression. Ventilation systems should maintain fresh air exchange rates appropriate for pig density and age while minimizing drafts that chill pigs. Temperature setpoints should account for pig age and size, with younger pigs requiring warmer conditions. Humidity management helps maintain respiratory tract defenses, with excessively dry air irritating respiratory epithelium. Air inlet placement and barn design should minimize direct air drafts across pigs while ensuring adequate fresh air supply.

Seasonality of swine influenza necessitates heightened awareness during fall and winter months when outbreaks most commonly occur. Vaccination program timing should ensure protective immunity is present before peak influenza season. Enhanced environmental monitoring during cold weather periods catches ventilation problems before they stress pigs. Personnel policies regarding farm entry by individuals with respiratory illness should be emphasized during human influenza season, given the bidirectional transmission risk between humans and pigs.

Record systems supporting influenza management track clinical observations, diagnostic submissions, vaccination histories, and production parameters. Weekly mortality and morbidity recording allows trending that identifies emerging problems. Feed and water disappearance records reveal appetite changes that may signal subclinical disease. Vaccination records ensure compliance with program protocols and provide documentation for quality assurance purposes. Diagnostic submission histories inform vaccine strain selection and track circulation patterns over time.

Economic analysis of swine influenza impacts and control costs guides management decisions. Direct costs include mortality losses, treatment expenses, and vaccination program costs. Indirect costs encompass reduced growth rates, poorer feed efficiency, extended time to market weight, and labor for enhanced management during outbreaks. Cost-benefit analysis of vaccination programs should consider both prevention of clinical disease and reduction of production impacts from subclinical infection. Understanding the full economic picture helps producers make informed decisions about investment in influenza control measures.

Swine influenza affects all domestic pig breeds with similar susceptibility to infection, as no breed-specific resistance has been identified. However, production system characteristics associated with different breeding populations influence exposure risk and clinical outcomes. Pigs from high-health genetic nucleus herds may enter commercial production as naive animals susceptible to endemic influenza strains circulating in grow-finish facilities. Crossbred commercial pigs from diverse genetic backgrounds represent the majority of influenza-affected animals simply due to their numerical predominance in commercial production.

Production type influences influenza epidemiology through differences in management practices and pig flow patterns. Breeding herd populations typically experience endemic influenza circulation, with periodic introduction of new strains through replacement gilt entry or human-to-pig transmission. Sow vaccination programs aim to maintain immunity that limits viral shedding and provides maternal antibody transfer to piglets. Nursery and finishing populations face exposure risk when maternal antibody wanes and pigs encounter circulating strains, making these phases the primary target for growing pig vaccination programs.

Show pigs and exhibition swine represent a particular risk category for influenza due to their congregation at fairs, shows, and exhibitions where pigs from multiple sources intermingle. These events have been documented as amplification and transmission sites for influenza, including novel variant viruses with pandemic potential. Youth exhibitors and their families face zoonotic transmission risk through close contact with infected pigs. Breed associations and fair organizers have implemented biosecurity recommendations addressing influenza risk, though implementation varies. Veterinary oversight of exhibition swine health and influenza monitoring contributes to protecting both animal and public health.

The porcine respiratory disease complex encompasses the constellation of respiratory conditions most closely related to swine influenza, reflecting the synergistic interactions between multiple pathogens affecting pig respiratory health. PRRS virus infection frequently co-occurs with influenza, with dual infection producing more severe clinical disease than either pathogen alone. The immunosuppressive effects of PRRSV increase susceptibility to influenza infection and worsen clinical outcomes. Mycoplasma hyopneumoniae causes chronic respiratory disease that compounds with influenza to increase overall pneumonia severity. Understanding these interactions guides comprehensive respiratory disease control programs.

Secondary bacterial pneumonias represent the most clinically significant conditions associated with influenza, as bacterial complications cause the majority of influenza-related mortality. Pasteurella multocida commonly colonizes the upper respiratory tract and opportunistically invades damaged lower respiratory epithelium following influenza infection. Actinobacillus pleuropneumoniae causes fibrinous and hemorrhagic pneumonia that can be rapidly fatal in influenza-compromised pigs. Streptococcus suis produces pneumonia, meningitis, and septicemia in pigs with influenza-induced immune depression. Effective influenza management includes prevention and treatment of these bacterial complications.

Other viral respiratory pathogens may co-circulate with influenza and complicate differential diagnosis. Porcine circovirus type 2 contributes to respiratory disease through its immunosuppressive effects and direct lung involvement. Porcine respiratory coronavirus causes generally mild respiratory disease that may be confused with influenza in its clinical presentation. Pseudorabies virus, in regions where it remains present, causes respiratory and neurological disease that must be differentiated from influenza. Comprehensive diagnostic approaches testing for multiple pathogens provide the clearest picture of respiratory disease etiology in affected herds.